Ò»¾Å¾Å°ËÄ격ʿÑо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ
JM53sx4&
v|@EuN14<
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© =%B}8$.|
urQ<r{$x0
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© N37CAbw0
E#cu}zi
1.Co-stimulators (or co-stimulating molecules) hI*6f3Vn(n
9Fg:
2.NK-kB iEbW[sX[4
8
k_hX^
3.Immunoglobulin superfamily X<f4X"y
V|<'o<h8
4.antigen-presenting cell (APC) FMitIM*]
HaR x(p0
5.death domain gRZ!=z[&
#fXy4iL l
6.CCR and CXCR Qz$Wp*
l .m #
7.Lectin (or mitogen) Zj0h0Vt
4z^~,7J^
8.Clusters of differentiation, CD) (.b!kfC
@[Wf!8_
9.B7 family ${97G#
BLm}mb#/{
10.Cytotoxic T lymphocyte, CTL) 'G`xD3 E3,
>VG*La'c
11.IL-15 and IL-15 receptor (IL-15R) <d{>[R)
zY].ZS=7
12.MHC restriction "i!W(}x+
I}awembw g
13.Affinity-chromatography _&]Gw, ~/i
y"H(F,(N
14.Cyctosprin A, CsA }t1 q5@QU
D"{%[;J
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) n+s=u$%qn
Q{~;4+ZD
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© 9rM#w"E?<
DH.CAV
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 i{r[zA]$
uY3?(f#
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ ,5x9o"N!
_gpf9ad
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢½á¹¹¼°Æäʶ±ð ¿¹ÔµÄÌØµã¡£ mw83 pU6
U:|:Y=O?Q
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© S=$ \S9
O`;o"\P<
ÃâÒßѧרҵ£º g c<Y?a-
}RQHsS
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ ]zI*}(adu
C`
8.8
Ïû»¯ÄÚ¿Æ£º 6-\M }xq?
XMLl>w2z
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ j% '~l#nw
[6nN]U~ Y
ѪҺ²¡Ñ§×¨Òµ£º g? C<@
A=np?wc
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿